Skip to content
lsd.com

Arizona

Psychedelic trials in Arizona

12 registered trials has a study site in Arizona, and 2 are recruiting now.

12
Trials with a site here
2
Recruiting
14
Facilities

Open now

Recruiting in this state

TrialStatusPhaseSubstanceSites
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL LimitedRecruitingPhase 3psilocybin68
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.NCT07347405 · Francisco A MorenoRecruitingPhase 1psilocybin1

Facilities

Where the research happens in Arizona

FacilityCityTrials
Scottsdale Research InstitutePhoenix3
Lighthouse PsychiatryGilbert2
The Clinical and Translational Sciences Research CenterTucson1
Phoenix VA Health Care System, Phoenix, AZPhoenix1
Mountain Clinical TrialsPhoenix1
Noble Clinical ResearchTucson1
Del Sol Research ManagementTucson1
University of Arizona College of Medicine - TusconTuscon1
Lighthouse Psychiatry ScottsdaleGilbert1
Metropolitan Neuro Behavioral InstituteChandler1
University of Arizona-TucsonTucson1
Mayo Clinic in ArizonaScottsdale1
Yuma Regional Medical CenterYuma1
University of ArizonaTucson1

Stay told

When a trial opens in Arizona

Research alerts

Get a notification when a trial for trials in Arizona starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

All trials

Every trial with a Arizona site

TrialStatusPhaseSubstanceSites
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderNCT06793397 · Cybin IRL LimitedRecruitingPhase 3psilocybin68
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.NCT07347405 · Francisco A MorenoRecruitingPhase 1psilocybin1
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · VA Office of Research and DevelopmentWithdrawnPhase 4ketamine26
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"NCT06564818 · Cybin IRL LimitedActive, not recruitingPhase 3psilocybin45
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268 · COMPASS PathwaysCompletedPhase 3psilocybin40
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940 · COMPASS PathwaysActive, not recruitingPhase 3psilocybin116
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)NCT06741228 · Definium Therapeutics US, Inc.Active, not recruitingPhase 3lsd34
54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideNCT03039192 · Janssen Research & Development, LLCCompletedPhase 3ketamine56
Psilocybin for Treatment of OCD-2NCT06992999 · Francisco A MorenoNot yet recruitingPhase 1 / Phase 2psilocybin1
Oral Ketamine in the Treatment of Depression and Anxiety in Patients With CancerNCT01680172 · Mayo ClinicTerminatedPhase 2ketamine2
Safety and Preliminary Efficacy of Organic Whole Psilocybin-Containing Mushrooms to Treat Patients Suffering From PTSDNCT07275970 · Scottsdale Research InstituteActive, not recruitingPhase 1psilocybin1
Psilocybin for Treatment of Obsessive Compulsive DisorderNCT03300947 · University of ArizonaCompletedPhase 1psilocybin1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states